358 related articles for article (PubMed ID: 3963588)
1. Neutrophil chemotaxis in rhesus macaques (Macaca mulatta).
Gonder JC; Thomas JM; Payne ES
Am J Vet Res; 1986 Apr; 47(4):860-2. PubMed ID: 3963588
[TBL] [Abstract][Full Text] [Related]
2. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay.
Quitt M; Torres M; McGuire W; Beyer L; Coates TD
J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
Webster RO; Goldstein IM; Flick MR
J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
[TBL] [Abstract][Full Text] [Related]
5. Chemotaxis of horse polymorphonuclear leukocytes to N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
Zinkl JG; Brown PD
Am J Vet Res; 1982 Apr; 43(4):613-6. PubMed ID: 7073083
[TBL] [Abstract][Full Text] [Related]
6. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy.
Mendonça MA; Cunha FQ; Murta EF; Tavares-Murta BM
Cancer Chemother Pharmacol; 2006 May; 57(5):663-70. PubMed ID: 16133528
[TBL] [Abstract][Full Text] [Related]
7. Chemotaxis of radiolabeled equine neutrophils.
Camp CJ; Leid RW
Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug as tools for analysis of neutrophil functions.
Périanin A; Giroud JP; Hakim J
Biomed Pharmacother; 1987; 41(6):315-21. PubMed ID: 3446289
[TBL] [Abstract][Full Text] [Related]
9. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis.
Partsch G; Schwarzer C
J Biolumin Chemilumin; 1991; 6(3):159-67. PubMed ID: 1660670
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
Azuma Y; Kosaka K; Kashimata M
Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
[TBL] [Abstract][Full Text] [Related]
11. Chemotactic factor induced neutrophil shape changes in whole blood. A comparison of adults and neonates.
Davis BH; Bronspiegel N; Krause PJ; Clark DA
Ann Clin Lab Sci; 1985; 15(6):495-503. PubMed ID: 4062230
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil function in the dog: shape change and response to a synthetic tripeptide.
Stickle JE; Kwan DK; Smith CW
Am J Vet Res; 1985 Jan; 46(1):225-8. PubMed ID: 3970429
[TBL] [Abstract][Full Text] [Related]
13. Homologous priming in chemotactic peptide-stimulated neutrophils.
Bellavite P; Chirumbolo S; Lippi G; Guzzo P; Santonastaso C
Cell Biochem Funct; 1993 Jun; 11(2):93-100. PubMed ID: 8391938
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of granulocyte deformability following exposure to chemotactic stimuli.
Pécsvárady Z; Fisher TC; Fabók A; Coates TD; Meiselman HJ
Blood Cells; 1992; 18(2):333-52; discussion 353-8. PubMed ID: 1450430
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
[TBL] [Abstract][Full Text] [Related]
16. Chemotactic peptide binding by intact neutrophils from human neonates.
Strauss RG; Snyder EL
Pediatr Res; 1984 Jan; 18(1):63-6. PubMed ID: 6322097
[TBL] [Abstract][Full Text] [Related]
17. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
18. Removal of human polymorphonuclear leukocyte surface sialic acid inhibits reexpression (or recycling) of formyl peptide receptors. A possible explanation for its effect on formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
Perez HD; Elfman F; Lobo E
J Immunol; 1987 Sep; 139(6):1978-84. PubMed ID: 3624873
[TBL] [Abstract][Full Text] [Related]
19. Differences among primates in defence against infection: sensitivity of polymorphonuclear leukocytes to fMet-Leu-Phe.
Suzuki K; Asaoka K; Takahashi K; Fujikura T
Cell Biochem Funct; 1985 Oct; 3(4):297-303. PubMed ID: 3013451
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
Cotter TG; Keeling PJ; Henson PM
J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
